GLP-1 receptor agonists and their role in managing type 2 diabetes.
Br J Community Nurs
; 29(8): 391-396, 2024 Aug 02.
Article
de En
| MEDLINE
| ID: mdl-39072740
ABSTRACT
Until recently the focus in diabetes care was on managing blood glucose - a glucocentric view. This is changing to a more holistic model aimed at prevention, treatment and management through lifestyle interventions as well as medication. An estimated 5 million people in the UK are living with diabetes, most have type 2 diabetes which is associated with obesity. Type 2 diabetes can be prevented, treated with diet and weight loss, or managed with medication. The number of people with diabetes has reached epidemic proportions. To manage diabetes well and reduce complications of poorly managed diabetes, management of the condition can no longer be restricted to endocrinologists and diabetes specialist nurses. This article provides guidance on how glucagon-like peptide-1 receptor agonists can be used in the management of type 2 diabetes.
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Diabète de type 2
/
Récepteur du peptide-1 similaire au glucagon
/
Hypoglycémiants
Limites:
Humans
Pays/Région comme sujet:
Europa
Langue:
En
Journal:
Br J Community Nurs
Sujet du journal:
ENFERMAGEM
Année:
2024
Type de document:
Article